Multiple myeloma (MM) is a cancer of certain cells in the blood, called plasma cells.
The cause of MM is not known, and currently there is no cure. However, there are a number of treatment options available that can lead to remission. For some people with MM, remission can last many years.
Patients who have already been treated with some available therapies but continue to have progression of their disease have “relapsed” or “refractory” MM. This means that their cancer has reoccurred after they have received initial treatments.
Patients with relapsed/refractory MM have fewer treatment options, and more therapies that may offer these patients treatment alternatives.